1202645-17-7

Basic information

• Product Name: (E)-tert-butyl 3-((diMethylaMino)Methylene)-4-oxopiperidine-1-carboxylate
• Synonyms: (E)-tert-butyl 3-((diMethylaMino)Methylene)-4-oxopiperidine-1-carboxylate;tert-butyl(E)-3-((dimethylamino)methylene)-4-oxopiperidine-1-carboxylate;EOS-60914
• CAS NO: 1202645-17-7
• Molecular Formula: C13H22N2O3
• Molecular Weight: 254.32538
• Mol File: 1202645-17-7.mol
• Article Data: 51

Chemical Properties

• Boiling Point: 357.9±42.0 °C(Predicted)
• Appearance: /
• Density: 1.144±0.06 g/cm3(Predicted)
• PKA: 5.07±0.20(Predicted)
• CAS DataBase Reference: (E)-tert-butyl 3-((diMethylaMino)Methylene)-4-oxopiperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-tert-butyl 3-((diMethylaMino)Methylene)-4-oxopiperidine-1-carboxylate(1202645-17-7)
• EPA Substance Registry System: (E)-tert-butyl 3-((diMethylaMino)Methylene)-4-oxopiperidine-1-carboxylate(1202645-17-7)

Safety Data

• Hazardous Substances Data: 1202645-17-7(Hazardous Substances Data)

Usage

Description

(E)-tert-butyl 3-((diMethylaMino)Methylene)-4-oxopiperidine-1-carboxylate is a chemical compound belonging to the class of piperidine derivatives. It features a tert-butyl group and a methylamino group attached to its carbon backbone, characterized by a molecular formula of C13H24N2O3. This yellowish liquid exhibits a slightly fruity odor and is soluble in organic solvents like ether and chloroform. Due to its potential for causing skin and eye irritation, it requires careful handling and use in well-ventilated areas with proper personal protective equipment.

Uses

Used in Pharmaceutical Industry:
(E)-tert-butyl 3-((diMethylaMino)Methylene)-4-oxopiperidine-1-carboxylate is used as a reagent in the pharmaceutical industry for the synthesis of various drugs. Its unique chemical structure allows it to serve as an intermediate in the production of a range of pharmaceutical compounds, contributing to the development of novel medications.
Used in Agrochemical Industry:
In the agrochemical industry, (E)-tert-butyl 3-((diMethylaMino)Methylene)-4-oxopiperidine-1-carboxylate is utilized as an intermediate in the synthesis of agrochemicals. Its role in this sector is crucial for the development of new pesticides, herbicides, and other agricultural products that aim to improve crop yield and protect plants from pests and diseases.
Organic Synthesis:
(E)-tert-butyl 3-((diMethylaMino)Methylene)-4-oxopiperidine-1-carboxylate is also used in organic synthesis as a versatile reagent. Its chemical properties enable it to participate in various reactions, facilitating the creation of a wide array of organic compounds for different applications across various industries.

Upstream product

• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 4637-24-5 N,N-dimethyl-formamide dimethyl acetal 
• 5815-08-7 tert-Butoxybis(dimethylamino)methane 
• 1188-33-6 N,N-dimethylformamide diethyl diacetal 
• 127-19-5 N,N-dimethyl acetamide 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 157327-49-6 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine dihydrochloride 
• 900156-22-1 tert-butyl 2-methoxy-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carboxylate 
• 259809-79-5 tert-butyl 2-(methylsulfonyl)-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate 
• 578713-43-6 N,N-Dimethyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-amine 
• 259809-78-4 t-butyl-2-(methylthio)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-6-carboxylate 
• 1383776-04-2 2-((3-chlorophenyl)amino)-N-ethyl-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxamide 
• 1383775-76-5 N-(3-chlorophenyl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-amine 
• 1383776-09-7 N-(3-chlorophenyl)-6-(pyridin-2-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-amine 
• 1383776-10-0 6-(1-(tert-butyl)-1H-tetrazol-5-yl)-N-(3-chlorophenyl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-amine 
• 1383776-12-2 N-(3-chlorophenyl)-6-(1-isopropyl-1H-tetrazol-5-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-amine 
• 1454656-61-1 6-(2-methanesulfinyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl)-pyridine-2-carboxylic acid (4-isopropyl-phenyl)-amide 
• 1454656-47-3 6-{2-amino-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-6-yl}-N-[4-(isopropyl)phenyl]pyridine-2-carboxamide 
• 1454656-60-0 N-(4-isopropylphenyl)-6-[2-(methylthio)-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl]pyridine-2-carboxamide 
• 1454657-51-2 methyl-4-methyl-3-[2-(methylsulfanyl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-6-yl]benzoate 

Relevant articles and documents

A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitors

Through an internal virtual screen at GlaxoSmithKline a distinct class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitors were discovered. Careful evaluation of crystal structures and SAR led to a novel, potent, and orally active imidazopyridine inhibitor of H-PGDS, 20b. Herein, describes the identification of 2 classes of inhibitors, their syntheses, and their challenges.

METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED RESISTANCE TO RAS INHIBITORS

The present disclosure relates to compositions and methods for the treatment of diseases or disorders (e.g., cancer) with bi-steric inhibitors of mTOR in combination with RAS inhibitors. Specifically, in some embodiments this disclosure includes compositions and methods for inducing apoptosis of tumor cells and/or for delaying, preventing, or treating acquired resistance to RAS inhibitors using bi-steric mTOR inhibitors.

Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffold

A series of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffold were identified with good cellular and human whole blood activity against IDO1. These inhibitors contain multiple chiral centers and all diastereomers were separated. The absolute stereochemistry of each isomers were not determined. Compounds 15 and 27 stood out as leads due to their good cellular as well as human whole blood IDO1 inhibition activity, low unbound clearance, and reasonable mean residence time in rat cassette PK studies.